Recently, Abbot made an announcement about their future plans to manage the crisis.
Recently,Abbott announcedthey would begin building a $500 million facility to produce specialty and metabolic infant formula.
Pharmaceutical Company Plans Multi-Million Dollar Facility To Produce More Infant Formula
Could this be the beginning of the end of the baby formula shortage?
